Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03496376
Other study ID # 1925-GOA
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date May 2, 2017
Est. completion date June 7, 2018

Study information

Verified date July 2018
Source Dokuz Eylul University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study was to investigate the effect of kinseio taping on functional capacity, pulmonary functions, respiratory muscle strength, severity of dyspnea, severity of fatigue in Chronic Obstructive Pulmonary Disease (COPD). Assessment of patients was done baseline and 6th week.

Eligible patients for the study randomly allocated to Kinesio Taping Group (KTG), or Control Group (CG). Both groups received three different deep breathing exercises (diaphragmatic, thoracic, and lateral basal), each consisting of three sets of 10 repetitions, with 30 seconds of rest between each set. KTG also received thoracic kinesio taping application.


Recruitment information / eligibility

Status Completed
Enrollment 27
Est. completion date June 7, 2018
Est. primary completion date May 31, 2018
Accepts healthy volunteers No
Gender All
Age group 40 Years to 80 Years
Eligibility Inclusion Criteria:

- aged 40 years and older,

- having stage II-III COPD diagnosis according to GOLD system and BODE Index by chest physician,

- unwilling to participate in any kind of pulmonary rehabilitation program for COPD,

- able to read, write, and understand Turkish; and

- willing and able to attend the study.

Exclusion Criteria:

- being in COPD exacerbation period,

- having neurological or musculoskeletal problems that would affect physical mobility,

- having unstable, severe heart disease(s) (heart failure, unstable hypertension, previous angina pectoris or myocardial infarction, heart valve problems),

- having scar, lesion or incision in the area of kinesio tape application,

- previous use of kinesio tape,

- having skin sensitivity against kinesio tape,

- malignancy,

- having mental and cognitive disorders that would affect cooperation.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Kinesio Taping
The material used for thoracic kinesio taping application was Kinesio® Tex Gold™ (Kinesio Holding. Patients were instructed to sit upright on an armless chair with no back support, with knees flexed to 90 degrees, feet on the floor and arms relaxed. Kinesio tape was applied anteriorly and posteriorly to facilitate respiratory muscles (primarily diaphragm) along the subcostal area. Additionally, two more kinesio tapes were applied to upper trapezius and scalene muscles' area which lies between neck and acromion at both sides (left and right).
Deep Breathing Exercises
Three different deep breathing exercises (diaphragmatic, thoracic, and lateral basal), each consisting of three sets of 10 repetitions, with 30 seconds of rest between each set.

Locations

Country Name City State
Turkey Dokuz Eylül Üniversitesi School of Physical Therapy and Rehabilitation Izmir

Sponsors (1)

Lead Sponsor Collaborator
Dokuz Eylul University

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in functional capacity Six-minute walk test (6MWT) is a valid, reliable and useful test for assessing functional capacity of COPD patients. This test assesses distance walked over 6 minutes as a sub-maximal test of aerobic capacity/endurance. Baseline, 6th week
Secondary Change in pulmonary functions Pulmonary function test (PFT) is a generic term used to indicate a battery of studies or maneuvers that may be performed using standardized equipment to measure lung function. Baseline, 6th week
Secondary Change in respiratory muscle strength Measurement of respiratory muscle strength is useful in order to detect respiratory muscle weakness and to quantify its severity. Respiratory muscle strength is assessed by mouth pressures sustained for 1 s during maximas static manoeuvre against a closed shutter. Baseline, 6th week
Secondary Change in severity of dyspnoea Modified Medical Research Council (mMRC) dyspnea scale is a valid and reliable test for measuring the severity of dyspnea of COPD patients. This scale ranges from 0 to 4. A higher value represents a worse outcome. Baseline, 6th week
Secondary Change in severity of fatigue Modified Borg Scale (MBS) is a useful scale for severity of fatigue. This scale ranges from 0 to 10. A higher value represents a worse outcome (0=not at all, 10=maximal). Baseline, 6th week
See also
  Status Clinical Trial Phase
Recruiting NCT03640260 - Respiratory Regulation With Biofeedback in COPD N/A
Recruiting NCT03284203 - Feasibility of SpiroPD N/A
Not yet recruiting NCT03644888 - Continuous Chest Wall Vibration in COPD Rehabilitation N/A
Enrolling by invitation NCT03468101 - Characterization of Professional COPD Related to Exposure to Organic Dust - Mean Follow up at 6 Years
Not yet recruiting NCT03655795 - Autologous Transplantation of Bronchial Basal Cells for Treatment of COPD Phase 1
Not yet recruiting NCT03611036 - Effect of Different Form of Upper Limb Muscles Training on Dyspnea in COPD N/A
Not yet recruiting NCT03278795 - VSV Versus PSV as a Weaning Mode of Mechanically Ventilated Chronic Obstructive Pulmonary Disease Patients N/A
Recruiting NCT02815683 - Bronchoscopic EmphysemA Treatment in THE NetherLands N/A
Not yet recruiting NCT02914093 - IMT in Hypercapnic Patients With COPD N/A
Not yet recruiting NCT02881385 - Effects on Respiratory Patterns and Patient-ventilator Synchrony Using Pressure Support Ventilation N/A
Recruiting NCT02515318 - Physiotherapy in Acute Exacerbation of Chronic Obstructive Pulmonary Disease N/A
Recruiting NCT02807025 - Nasal, Tracheal and Bronchial Mucosal Lining Fluid(MLF) Sampling From Patients With Respiratory Diseases N/A
Completed NCT02509299 - Effect of Physiotherapy on Perceived Health Status in Hospitalized COPD Patients N/A
Completed NCT03028701 - Assessment of Bronchodilator Efficacy of Formoterol/Budesonide 12/400 mcg Via Discair in COPD Phase 4
Completed NCT02517411 - Physiotherapy in Patients With Stable Chronic Obstructive Pulmonary Disease N/A
Completed NCT02750189 - The Economic Burden of Chronic Obstructive Pulmonary Disease(COPD) in South Korea N/A
Recruiting NCT03026439 - Searching Chronic Obstructive Pulmonary Disease Onset N/A
Recruiting NCT02735954 - Colorado Marijuana Users Health Cohort
Recruiting NCT02236039 - COPD Originates in Polluted Air N/A
Recruiting NCT02223780 - Early Palliative Care for Patients With Severe and Very Severe COPD: a Randomised Study N/A